Renee Wonlai Lo awarded 17,700 RSUs at Integra LifeSciences (IART)

Rhea-AI Filing Summary

Lo Renee Wonlai reported acquisition or exercise transactions in this Form 4 filing.

INTEGRA LIFESCIENCES HOLDINGS CORP director Renee Wonlai Lo received a grant of 17,700 restricted stock units (RSUs) as equity compensation. Each RSU represents a contingent right to receive one share of IART common stock. The RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026, and this award brings her reported RSU holdings to 17,700 units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lo Renee Wonlai

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	17,700	$0.00	--

Holdings After Transaction: Restricted Stock Units — 17,700 shares (Direct, null)

Footnotes (1)

1. Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026.

Key Figures

RSUs granted: 17,700 units Underlying common shares: 17,700 shares Exercise price: $0.00 per unit +2 more

5 metrics

RSUs granted 17,700 units Restricted Stock Units granted on May 7, 2026

Underlying common shares 17,700 shares Each RSU represents one share of common stock

Exercise price $0.00 per unit RSU grant price per unit

Post-grant RSU holdings 17,700 units Total RSUs following this transaction

Vesting date May 7, 2026 RSUs vest in full on one-year anniversary

Key Terms

Restricted Stock Units, Equity Incentive Plan, contingent right, vest in full

4 terms

Restricted Stock Units financial

"Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

contingent right financial

"Each RSU represents a contingent right to receive one share of IART common stock"

vest in full financial

"RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lo Renee Wonlai

(Last) (First) (Middle)

1100 CAMPUS ROAD

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	05/07/2026		A		17,700		(2)	(2)	Common Stock	17,700	$0	17,700	D

Explanation of Responses:

1. Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock.

2. RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026.

Remarks:

	/s/ Michael D. Hutchinson; Attorney-in-Fact for Renee Wonlai Lo	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Integra LifeSciences (IART) report for Renee Wonlai Lo?

Integra LifeSciences reported that director Renee Wonlai Lo received a grant of 17,700 restricted stock units. These RSUs are a form of equity compensation and each unit represents a contingent right to receive one share of IART common stock upon vesting.

How many Integra LifeSciences RSUs were granted to director Renee Wonlai Lo?

Renee Wonlai Lo was granted 17,700 restricted stock units. This entire amount is tied to Integra LifeSciences common stock, with each RSU convertible into one share after vesting, aligning the director’s compensation more closely with shareholder interests over time.

When do Renee Wonlai Lo’s Integra LifeSciences RSUs vest?

The RSUs granted to Renee Wonlai Lo vest in full on the one-year anniversary of the grant date of May 7, 2026. Full vesting on a single date creates a clear timeline for when the restricted stock units convert into common shares.

What does each Integra LifeSciences RSU granted to Renee Wonlai Lo represent?

Each restricted stock unit granted to Renee Wonlai Lo represents a contingent right to receive one share of Integra LifeSciences common stock. The units have no exercise price and will convert into shares only after they fully vest according to the specified vesting schedule.

Under which plan were Renee Wonlai Lo’s Integra LifeSciences RSUs granted?

The RSUs were granted under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. This plan governs equity-based awards such as restricted stock units granted to directors, officers, and other eligible participants of the company.